PGD-A: the exam that could change the lives of IVF patients

PGD-A: the exam that could change the lives of IVF patients
A transpartisan bill wants to authorize preimplantation diagnosis of aneuploidies in France. This exam, practiced in almost all of Europe, is today banned in France. The text will be debated in the National Assembly in early December 2026.

Hormonal injections, punctures, transfers, miscarriages. For thousands of women, the medically assisted procreation (AMP) pathway feels like a marathon without a finish line.

What if an exam made it possible to avoid some of these failures? This is the whole point of
DPI-Aat the heart of a proposed law which will be examined during the transpartisan week at the beginning of December. According to the BAMP Collective, a patients’ association, it would put an end to “a French exception”.

What exactly is DPI-A?

THE preimplantation diagnosis of aneuploidies
(PGD-A) is carried out on embryos obtained by in vitro fertilization (IVF), before their transfer into the uterus.

Its principle is simple: check the number of chromosomes of each embryo. A chromosomal abnormality most often prevents a full-term pregnancy from occurring.

According to the press release from the BAMP Collective, these anomalies are responsible for the almost all miscarriages. PGD-A therefore makes it possible to exclude embryos that will not be able to develop. He doesn’t look for gender, eye color, or any ability.

Three out of four transfers without birth

The figure is striking. According to the BAMP Collective, more than 65,000 embryo transfers do not result in any births in France each year. It is three transfers out of four.

Behind these statistics, there are trying journeys:

  • Heavy hormonal treatments;
  • Ovarian punctures;
  • Repeated miscarriages;
  • Sometimes medical terminations of pregnancy.

The Collective speaks of a physical, psychological and financial exhaustionlived “in the silence of the taboo of infertility”.

Juliette, a volunteer with the Collective, says she was chained
eight embryo transfers in France, eight failures. In Spain, PGD-A showed that half of its embryos were not viable. She became pregnant during the first transfer that followed.

Going abroad: a question of money

Unable to access it in France, thousands of couples leave each year for Spain, Belgium, the Czech Republic or Greece, depending on the Collective.

The average cost of IVF abroad is 6,000 to 10,000 eurosentirely at the expense of the patients. DPI-A alone would cost approximately 500 euros.

Result, denounces the association: a two-tier medicine. Those who can afford it cross the border. The others remain on a journey whose outcome is often uncertain.

This inequality of access to care was highlighted by the
National Consultative Ethics Committee (CCNE) and by theParliamentary Office for the Evaluation of Scientific and Technological Choices (OPECST).

Neither “à la carte babies”, nor eugenics

The subject touches on sensitive ethical questions. The press release responds directly to this.

He cites theCCNE opinion no. 138according to which PGD-A selects “more viable embryos, not more desirable embryos”.

The BAMP Collective also distinguishes this practice from eugenics, which involves a state project aimed at selecting a population. DPI-A is presented as an individual choiceoffered to couples in medical difficulty.

What does the proposed law provide?

Supported by the MP Constance de Pélichy
(LIOT) and co-signed by nearly ninety deputies from eight political groupsthe bill sets a strict framework:

  • Limiting medical indications : maternal age, repeated implantation failures, repeated miscarriages, increased risk of aneuploidy;
  • The explicit ban to research sex or any other genetic characteristic;
  • A collegial decision taken on a case-by-case basis;
  • Written consent ;
  • Monitoring by the Biomedicine Agency ;
  • A three-year parliamentary evaluation.

“It does not reopen a major social debate. She catches up on medical delays, within a strict and evaluated framework.“, defends Constance de Pélichy.

Scientific and institutional support

According to the press release, PGD-A has been practiced for more than twenty years in almost all European countries, including Spain, Italy, Belgium, Portugal, the United Kingdom, Denmark and the Czech Republic, without observed drift.

It is the subject of an international consensus, supported by learned societies ASRM and ESHRE. In France, it is based on:

  • L’CCNE opinion ;
  • THE OPECST report (July 2026);
  • There recommendation no. 36 of the Fertility Plan steering committee, submitted in October 2026.

For Dr Xavier Pollet-Villard, a medical biologist specializing in AMP, it is not a question of experimenting: “We authorize it, we supervise it, we evaluate it.”

The next meetings

The BAMP Collective, which has existed since 2013, supports people undergoing IVF. He recalls that the stories of suffering have been repeated for thirteen years.

Two dates to remember:

  • Wednesday November 18, 2026, from 3 p.m. to 5:30 p.m. : transpartisan conference at the National Assembly, as part of Infertility Awareness Month. Registrations are made on Billetweb.
  • Early December 2026 : debate in the National Assembly during the transpartisan week.

The Collective also publishes a testimonial book, “We just want to have babies.”with dozens of patient stories. It is prefaced by Virginie Rio, co-founder of the Collective, and by Professor Samir Hamamah, co-chair of the Fertility Plan steering committee. The full version can be downloaded from bamp.fr.